Our study aims at testing the accuracy of CK-18-M30, FGF-21, IL-1Ra, PEDF and OPG in non-invasive diagnosis of NAFLD and NASH. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatohepatitis.